PUBLISHER: Bizwit Research & Consulting LLP | PRODUCT CODE: 1510236
PUBLISHER: Bizwit Research & Consulting LLP | PRODUCT CODE: 1510236
Europe Flow Diverters Market is valued at approximately USD 68.61 million in 2023 and is anticipated to grow with a healthy growth rate of more than 13.01% over the forecast period 2024-2032 Flow diverters are devices that are implanted in blood arteries to treat cerebral aneurysms, particularly those with large or wide necks. These stent-shaped items are inserted into the main artery to reroute blood flow away from the aneurysm, promoting blood clotting and arterial wall remodeling. Flow diverters reduce the probability of an aneurysm bursting while maintaining blood circulation to the surrounding branches. Moreover, the increasing adoption of minimally invasive procedures for treating cerebral aneurysms by advancements in medical technology and increasing preference towards safer treatment options is growing in the Europe Flow Diverter market.
The Europe Flow Diverters Market is driven by several factors such as technological advancements, increasing prevalence of complex aneurysms, and regulatory approvals facilitating market expansion. In Europe, growing healthcare expenditure is significantly driving the market. The increased funding for advanced medical technologies and procedures, including neurointerventional devices such as flow diverters. Higher healthcare expenditure supports hospitals and healthcare facilities in upgrading their abilities to offer advanced treatments, thereby enhancing the adoption of flow diverters among healthcare providers. However, complex regulatory approvals and cost concerns associated with flow diverter procedures are restricting the accessibility for certain patient populations and healthcare providers that can impact the market growth over the forecast period.
The key countries considered for the Europe Flow Diverters Market study includes UK, Germany, France, Italy, Spain, and Rest of Europe. In 2023, Germany is dominating the Europe Flow Diverters Market in terms of revenue. Germany has a robust healthcare infrastructure, high healthcare expenditures, and advanced technological capabilities in neurointerventional procedures. Germany has an ageing patient population requiring treatment for cerebral aneurysms, along with an active approach towards adopting innovative medical devices such as flow diverters. Additionally, the presence of prominent medical device manufacturers and research institutions in Germany drives the innovation and facilitate the rapid adoption of new technologies in neurosurgery and interventional radiology. Furthermore, the market in France is expected to develop at the fastest rate over the forecast period.